4-amino-4-methyl-2-pentyne-1-al has been researched along with methional in 1 studies
| Studies (4-amino-4-methyl-2-pentyne-1-al) | Trials (4-amino-4-methyl-2-pentyne-1-al) | Recent Studies (post-2010) (4-amino-4-methyl-2-pentyne-1-al) | Studies (methional) | Trials (methional) | Recent Studies (post-2010) (methional) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 58 | 1 | 16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chantepie, J; Fournet, G; Gore, J; Michal, Y; Quash, G; Raffin, C; Reichert, U | 1 |
1 other study(ies) available for 4-amino-4-methyl-2-pentyne-1-al and methional
| Article | Year |
|---|---|
A thioester analogue of an amino acetylenic aldehyde is a suicide inhibitor of aldehyde dehydrogenase and an inducer of apoptosis in mouse lymphoid cells overexpressing the bcl2 gene.
Topics: Aldehyde Dehydrogenase; Aldehydes; Animals; Apoptosis; Cell Line; DNA Fragmentation; Enzyme Inhibitors; Gene Expression; Growth Inhibitors; HeLa Cells; Humans; Lymphocytes; Mice; Proto-Oncogene Proteins c-bcl-2; Saccharomyces cerevisiae; Sulfhydryl Compounds | 1999 |